Page last updated: 2024-11-03

procarbazine and Dyspnea

procarbazine has been researched along with Dyspnea in 3 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Dyspnea: Difficult or labored breathing.

Research Excerpts

ExcerptRelevanceReference
"Pulmonary toxicity is a well recognised side effect of anticancer agents particularly bleomycin, cyclophosphamide, methotrexate, and busulphan."2.38Pulmonary toxicity following MOPP chemotherapy. ( Byrne, MJ; Cohney, SJ; Millward, MJ; Ryan, GF, 1990)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
O'Bryen, J1
Anderson, NR1
Collins, J1
Millward, MJ1
Cohney, SJ1
Byrne, MJ1
Ryan, GF1
Lowenthal, RM1
Jestrimski, KW1

Reviews

2 reviews available for procarbazine and Dyspnea

ArticleYear
Pulmonary toxicity following MOPP chemotherapy.
    Australian and New Zealand journal of medicine, 1990, Volume: 20, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dyspnea; Female; Hodgkin Disease; Humans; Lung

1990
Corticosteroid drugs: their role in oncological practice.
    The Medical journal of Australia, 1986, Jan-20, Volume: 144, Issue:2

    Topics: Adrenal Cortex Hormones; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast

1986

Other Studies

1 other study available for procarbazine and Dyspnea

ArticleYear
Heart on the wrong side.
    Australian journal of general practice, 2019, Volume: 48, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubici

2019